IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Propel Bio Management, LLC

Portfolio Profile

CIK: 0001969764 | Los Angeles, CA

Investment Profile

Style

Value

Turnover

High

Orientation

Concentrated trader
$191.1M
AUM
29
Positions
68.15%
Top 10 Conc.
97.54%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Plains GP Holdings LP-Cl(PAGPEUR)1,272,360$30.9M16.16%
2Achieve Life Sciences Inc(ACHV)4,034,018$26.3M13.79%
3Corcept Therapeutics Inc(CORT)136,499$11.9M6.21%
4Phathom Pharmaceuticals I(PHAT)1,050,358$11.4M5.96%
5Delcath Systems Inc(DCTH)871,460$11.0M5.74%

Sector Allocation

Latest filing, equity positions only

Healthcare80.07% · $153.0M
Unclassified19.93% · $38.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare77.8%80.07%+2.27%
Unclassified22.2%19.93%-2.27%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$120.6M | 34 pos.
$171.8M | 29 pos.
$154.2M | 25 pos.
$172.4M | 21 pos.
$100.7M | 21 pos.
$86.1M | 18 pos.
6
Milestone Pharmaceuticals(MIST)
7,429,590
$10.0M
5.21%
7Compass Pathways PLC(CMPS)573,086$8.1M4.24%
8Kyverna Therapeutics Inc(KYTX)883,198$7.9M4.12%
9Artiva Biotherapeutics in(ARTV)696,436$6.8M3.54%
10Abeona Therapeutics Inc(ABEO)983,070$6.1M3.18%
Cap SizePrev %Curr %Change
Small Cap42.11%37.62%-4.49%
Micro Cap28.49%35.55%+7.06%
Unclassified22.2%19.93%-2.27%
Mid Cap7.2%6.9%-0.3%
$82.4M | 16 pos.
$99.9M | 16 pos.
$117.1M | 20 pos.
$158.7M | 38 pos.
$191.1M | 29 pos.
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

4
New
13
Closed
11
Increased
10
Decreased
4
Unchanged